DEC 12, 2021 8:00 AM PST

Cyagen: One-Stop Research Model & Gene Therapy Solutions

SPONSORED BY: Cyagen

With gene therapy demonstrating an enormous potential to treat a wide range of diseases, Cyagen has added a range of gene therapy services to our comprehensive research model solutions. To further support scientists making notable advancements and ultimately benefiting patients around the world, we have established an innovative One-Stop Gene Therapy Research Solutions CRO Platform.

By utilizing Cyagen’s in-depth exploration in artificial intelligence (AI) with decades of genetic engineering data, we can provide scientists with advanced gene function analysis and one-stop gene therapy comprehensive solutions, including: target screening and function research, animal model construction, design and packaging of viral vectors such as AAV, LV and ADV, as well as phenotype analysis.

Our services include CRISPR Cas9 Screening & Target Validation, Custom Mouse Model Generation, Efficient Adenovirus/Lentivirus Packaging of adeno-associated virus (AAV), Lentivirus (LV), Adenovirus (ADV), Pharmacology and Pharmacodynamics (PD) Studies, and more.

Cyagen has over 15 years’ experience as an animal research model provider, having developed various robust platforms related to gene therapy, covering a variety of rare human diseases.

>>Learn More: One-Stop Gene Therapy Research Solutions

Viral Vector Design and Development

Cyagen has many years of experience in virus packaging, and can provide AAV, LV, ADV and other viruses that comply with different quality standards. Our virus packaging platform has been widely used in the construction of various cell line models and in vivo studies of living animals, and have been cited and published by customers in many journals. For AAV virus packaging, we adopt a three-plasmid co-transfection method. The advanced purification process can provide customized AAV packaging services with high purity, high titer, and different serotypes. It is especially suitable for in vivo animal experiments and can meet the personalized choices of gene therapy researchers.

>>Learn More: Viral Vector Design and Development

Animal Model Development and Support Services

As an international and innovative CRO provider of research model animals, Cyagen makes the establishment of gene-edited animal models more efficient through its self-developed TurboKnockout® technology and CRISPR-Pro technology. In addition, Cyagen can provide surgical disease models and gene therapy vector model construction services.

>>Learn More: Animal Model Construction Services

Effectiveness Evaluation

We offer a variety of effectiveness evaluation services for our gene therapy platform, including molecular, cellular (in vitro), and animal (in vivo) phenotypic testing services. Our services span the field of gene therapy, covering multiple diseases such as those affecting neurological, cardiovascular, and cerebrovascular systems, tumors, and more. We also provide customers with a comprehensive phenotype analysis system service platform to support every research model project.

>>Learn More: Gene Therapy Effectiveness Evaluation Services

Gene Therapy Case Study

The research groups of Dr. Bin Zhou and the team of Dr. Hefeng Huang co-published an article titled "In Vivo AAV-CRISPR/Cas9-mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia" in the journal Circulation. In this study, researchers find that adeno-associated virus (AAV) delivers CRISPR/Cas9 to achieve low-density lipoprotein receptor (LDLR) gene correction that can partially rescue LDLR expression and effectively ameliorate atherosclerosis phenotypes in Ldlr mutant mice generated by Cyagen. This finding provides a potential therapeutic method for the treatment of familial hypercholesterolemia (FH).

The Advantages of Cyagen

  • Full-service gene therapy CRO platform
  • Advanced bioinformatics platform
  • Leading AI technology supports the optimization and transformation of AAV
  • Risk prediction of pathogenic mutation site
  • In vivo and in vitro models: one-stop services

With more than 15 years’ experience in genetic engineering, Cyagen offers a complete range of model generation services, including: custom genetically engineered models, ready-to-use catalog models, drug development models, colony management, and phenotype analysis - enabling researchers worldwide to create, manage, and monitor models with ease. 

Get a Free Consultation

Request a free consultation and project quote now! You can always email animal-service@cyagen.com or call 800-921-8930 to inquire about our services or obtain a quote for your project.

 

We look forward to hearing from you!

 

About the Sponsor
Cyagen is a 700-employee company headquartered in Santa Clara, California, with additional locations in Japan and China. As a leading provider of complete research model solutions, we offer a “one-stop-shop” tailored to biomedical scientists’ gene research needs. Our custom murine model generation services range from DNA vector construction to embryonic stem cell manipulation, microinjection, breeding, and more. All projects are fully customizable and flexible.
You May Also Like
FEB 23, 2022
Drug Discovery & Development
Illicit Amphetamine Use Increases Psychosis Risk by 5 Times
FEB 23, 2022
Illicit Amphetamine Use Increases Psychosis Risk by 5 Times
The use of illicit amphetamines, commonly known as 'speed' increases the risk of psychosis 5-fold over a ten-yea ...
MAR 03, 2022
Drug Discovery & Development
Blood Pressure Drug Increases Natural Insulin Production in Type 1 Diabetes
MAR 03, 2022
Blood Pressure Drug Increases Natural Insulin Production in Type 1 Diabetes
Individuals with type 1 diabetes who take blood pressure medication verapamil require less insulin on a daily basis. The ...
APR 01, 2022
Drug Discovery & Development
Pill Form of Remdesivir Treats COVID-19 in Mice
APR 01, 2022
Pill Form of Remdesivir Treats COVID-19 in Mice
A pill form of remdesivir, an antiviral drug currently administered intravenously, may be able to treat COVID-19 in mice ...
APR 08, 2022
Drug Discovery & Development
Puberty-triggering Hormone Reverses Fatty Liver Disease in Mice
APR 08, 2022
Puberty-triggering Hormone Reverses Fatty Liver Disease in Mice
Kisspeptin, a hormone that triggers puberty and regulates fertility in humans, may be able to treat non-alcoholic fatty ...
APR 19, 2022
Health & Medicine
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
APR 19, 2022
Pandemic Creates Opportunity to Study Rare Vaccine Side Effects
The Global Vaccine Data Network (GVDN) is a project conceived over 10 years ago to study vaccine side effects. Back then ...
MAY 09, 2022
Cancer
A Gel Implant Protects from Cancer Recurrence
MAY 09, 2022
A Gel Implant Protects from Cancer Recurrence
Following a successful course of cancer treatment, a patient may enter remission. Remission, classified as either partia ...
Loading Comments...